Teva Hit With Immediate Appeal After Overcoming US Korlym IP
Corcept Therapeutics Says New Jersey Court Decision ‘Based On Legal, Factual Errors’
Teva has gone one better than earlier ANDA settlers Hikma and Sun after winning its long-running legal battle against Corcept Therapeutics over Korlym IP. However, the Israeli firm appears unlikely to launch at risk following an immediate appeal.
